Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BofA

New home inventory is at its highest level since just before the housing market collapse that led to the Great Recession, but that doesn't mean it's the same market

Since roughly 2022, ResiClub co-founder Lance Lambert told Fortune, "the national power dynamic has slowly been shifting from sellers to buyers."

Fortune

Boeing's Order Book Soars On Korean Air Mega-Deal And Hopes For China Sales

On Tuesday, Boeing Co. (NYSE:BA) secured a $36.2 billion deal with Korean Air for 103 planes, including a mix of 787, 777, and 737 passenger jets.

Benzinga

Streaming has Americans more glued to their screens than ever, but it could all come crashing down in the case of a ‘content recession,’ BofA says

The top 10% of American households are paying over $100 a month for streaming services. How much longer will they?

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump and Softbank Are Just ‘Noise’ for Intel. Here’s How Wall Street Really Thinks You Should Play INTC Stock.

Down 64% from all-time highs, Intel is a chip stock that might stage a rebound due to its strategic initiatives and AI investments. Is INTC stock a good buy today?

Barchart

You won't get more money from quitting in this economy, BofA says, as job-hopping freezes in white-collar America

Wage increases for job-hoppers have collapsed, BofA finds, while wage growth for job-switchers equals that of job-stayers for the first time since 2010.

Fortune

Is The Sydney Sweeney Boost Already Fading For American Eagle Stock?

American Eagle Outfitters Inc. (NYSE:AEO) shares slipped Monday after fresh concerns emerged over slowing sales momentum, tariff headwinds, and limited earnings visibility, raising doubts about the retailer’s ability to sustain its recent buzz from celebrity-driven marketing and denim demand.

Benzinga

Subdued FX volatility in August is unusual: BofA analysts

Increased volatility is expected for the U.S. dollar-Canadian dollar pair.

Fortune

Read news from The Economist, FT, and more,
with one subscription

BofA sees the replacement of people with process solving the 'productivity paradox,' because 'A process is almost free and it's replicable for eternity'

"I think people love this AI technology because it feels like sorcery," BofA's Savita Subramanian said. "The truth is it hasn't really changed the world that much yet, but I don't think it's something to be dismissed."

Fortune

Big Trouble At Lockheed As Classified Program Blowups Trigger Billions In Losses

Lockheed Martin Corp. (NYSE:LMT) reported $1.8 billion in charges in the second quarter, led by a classified Aeronautics program and two Rotary and Mission Systems projects, prompting Bank of America Securities (BofA) analyst Ronald J. Epstein to trim his outlook.

Benzinga

Beyond snubbing Tinder, Bumble, and casual flings, more than half of Gen Z is spending $0 monthly on dating, BofA finds

Gen Z’s economic anxiety—as well as disinterest in casual dating—has led many young people to spend little to nothing on dates.

Fortune

The last time the Fed cut rates against rising inflation was right before the Great Financial Crisis. BofA warns of the 'Ghosts of 2007'

Conditions are like they were in 2007, or in the late 1990s, depending on how you look at the Fed raising rates during rising inflation, and the top 50 stocks dominating.

Fortune

Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage

Carlsmed Inc. (NASDAQ:CARL), an AI-powered innovator in spine surgery, is poised for significant growth following key advancements and strong analyst projections.

Benzinga

GoodRx Is Soaring on a Novo Nordisk Deal. Should You Buy GDRX Stock Here?

GoodRx stock soars after announcing GLP-1 partnership with Novo Nordisk. A Bank of America analyst recommends selling GDRX shares into the strength before they crash again.

Barchart

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

More outages, aging infrastructure, and bicoastal dysfunction: BofA warns America’s grid is 30% to 46% ‘beyond its useful life’

Bank of America Institute warns: “Grid reliability is worse today than in the early 2000s.”

Benzinga

What's Going On With Coherent Stock On Thursday?

Coherent Corp. (NYSE:COHR) shares plummeted on Thursday after the company announced it will sell its aerospace and defense unit to Advent for $400 million.

Barchart

Should You Buy the Post-Earnings Dip in Pinterest Stock?

Pinterest stock slips despite reporting better-than-expected revenue and user growth in Q2. BofA analyst says PINS shares could climb significantly to $44.

Fortune

Bank of America sees stagflation, not recession—and no rate cut this year. It’s because of 2 specific Trump policies

It all comes down to the labor market, immigration, and tariffs. What is really going on in terms of how many workers are available?

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

As Super Micro Computer Stock Absolutely Plunges, Should You Buy the SMCI Dip?

Super Micro stock tanks on disappointing Q4 earnings and weaker-than-expected guidance. Here’s why SMCI shares aren’t worth buying on the post-earnings decline.

Fortune

Here’s what the doomsayers are getting wrong about the job market, according to a Wall Street veteran

“This implies that the weak gains in payrolls in recent months might have something to do with the supply of labor.”

Benzinga

Ford's Q2 Shines, But Analysts Warn Of Recall Hangover And Cost Pressures

Ford Motor Company (NYSE:F) shares are trading higher on Thursday after the automaker posted second-quarter results that exceeded Wall Street expectations on Wednesday, driven by solid vehicle volumes and favorable pricing trends.

Benzinga

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

Fortune

‘Not just a cyclical recovery, but a boom.’ BofA says a ‘key tail risk’ is that the Trump economy will actually start to take off

“Today a confluence of factors argue that the key tail risk that may not be priced in is not just a cyclical recovery, but a boom,” BofA Research analysts write.

Benzinga

Elevidys Halt Sparks Analyst Downgrades—Sarepta Races To Revise Label

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced Monday it will voluntarily and temporarily pause all U.S. shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, effective July 22.

Barchart

Is Bank of America Stock a Buy, Sell, or Hold After Q2 Earnings?

Is BofA’s Q2 revenue miss just a brief pause? Or a warning sign to rethink your position?

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.